Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PDF Version BRISBANE, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune

Tempest TherapeuticsApr 26 12:00

Buy Recommendation for Tempest Therapeutics Backed by Promising Cancer Drug Developments

TipRanksApr 9 23:25

Tempest Reports New Preclinical Data for TPST-1120 in RCC at the AACR Annual Meeting

PDF Version BRISBANE, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune

Tempest TherapeuticsApr 9 12:00

Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Byrna Technologies Inc. (NASDAQ:BYRN) rose sharply during Friday's session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition. Byrna Techno

BenzingaApr 6 01:06

Tempest Announces Publication of Positive Data From Phase 1 Trial of TPST-1120 in Patients With Advanced Solid Tumors in Journal of Cancer Research Communications

PDF Version TPST-1120, a first-in-class, oral, selective PPAR⍺ antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised cancersBased on subsequent positive r

Tempest TherapeuticsApr 4 12:00

Daily rights tracking | Tesla's deliveries fell far short of expectations! Large-cap buy order bets fell; Nikola options doubled, and the bearish ratio soared to 80%

Nvidia's overnight options traded 1.03 million, down 40% from the average daily volume, and slightly down to 57% from the bullish ratio. Calls due on Friday, with an exercise price of 900 US dollars, had the highest trading volume, with nearly 52,000 orders and about 10,000 unclosed positions.

Futu NewsApr 3 17:13